mail
versión imprimible
 
 

6th Macrophage-Directed Therapies Summit 2024

Evvnt Promotion / evvnt
-
01.10.2024 - 03.10.2024  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 7:30 AM - 5:45 PM
 
Temas de la conferencia
Despite toxicity concerns for CD47 targets in 2023, the macrophage therapies space remains determined to drive revolutionary treatments for oncology, autoimmunity, inflammation, neurodegenerative disorders, and beyond. From pioneering the next generation of CAR-M therapies to unveiling novel targets, this field is on a mission to learn from the past and spearhead pipelines into clinical development.
Organizador profesional (PCO)
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/2422009-3?pid=4832

Speakers: Bindu Varghese | Senior Director, In Vivo CAR-M Therapies Lead | Carisma Therapeutics, Charles Garvin | Chief Executive Officer | Riptide Bioscience, and more
 

Información e inscripción:

https://go.evvnt.com/2422009-2?pid=4832
Ms. Kelly Cassidy
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2999.00 - USD 5097.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Anästhesie in Entwicklungsländern e. V.Swiss Tropical and Public Health InstituteÖsterreichische Akademie der ÄrzteÖsterreichisches Rotes KreuzÄrztekammer für WienÄrzte der WeltHelix - Forschung & Beratung WienCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio Sanitario